| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/26/2007 | EP1836165A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases |
| 09/26/2007 | EP1835935A2 Compositions and methods for enhanced dendritic cell maturation and function |
| 09/26/2007 | EP1835930A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 09/26/2007 | EP1835929A2 Anti-kir combination treatments and methods |
| 09/26/2007 | EP1835926A2 Plasmin-inhibitory therapies |
| 09/26/2007 | EP1835915A2 Immune response modifier formulations and methods |
| 09/26/2007 | EP1835910A2 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 09/26/2007 | EP1835908A2 Indole derivatives with antitumor activity |
| 09/26/2007 | EP1835900A1 Sulfasalazine analogues as nf-kb inhibitors |
| 09/26/2007 | EP1835898A2 Methods for modulating tumor growth and metastasis |
| 09/26/2007 | EP1644049B1 Method and device for radiotherapy |
| 09/26/2007 | EP1559715B1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 09/26/2007 | EP1554298A4 Process for the preparation of 9-beta-anomeric nucleoside analogs |
| 09/26/2007 | EP1501485B1 High drug load tablet |
| 09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1391464B1 Anti-cd40 monoclonal antibody |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1322673B1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 09/26/2007 | EP1307187B1 Use of 13-cis retinoic acid for the treatment of emphysema |
| 09/26/2007 | EP1303520B1 Therapeutic compounds and methods |
| 09/26/2007 | EP1268416B1 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses |
| 09/26/2007 | EP1265596B1 Medical emulsion for lubrication and delivery of drugs |
| 09/26/2007 | EP1263928B1 Identification of antigenic peptides by cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 09/26/2007 | EP1198239B1 METHODS EMPLOYING BACTERIAL ParD kis/ParD kid TOXIN-ANTITOXIN SYSTEM FOR KILLING EUKARYOTIC CELLS |
| 09/26/2007 | EP1035865B1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/26/2007 | EP1025212B1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 09/26/2007 | CN101044247A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/26/2007 | CN101044242A Tumor specific antibody |
| 09/26/2007 | CN101044150A Bioreductively-activated prodrugs |
| 09/26/2007 | CN101044125A Heterocyclic compounds and methods of use |
| 09/26/2007 | CN101044114A Nitrobenzindoles and their use in cancer therapy |
| 09/26/2007 | CN101043900A 肽混合物 Peptide mixture |
| 09/26/2007 | CN101043892A Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor |
| 09/26/2007 | CN101043891A Therapeutic agents targeting the nc ca-atp channel and methods of use thereof |
| 09/26/2007 | CN101043885A Arene ruthenium (II) compounds and their use in cancer therapy |
| 09/26/2007 | CN101041689A Derivative of cyclosporins C and D and pharmaceutical composition thereof |
| 09/26/2007 | CN101041686A Wood frog anticancer peptide and preparation method thereof |
| 09/26/2007 | CN101041680A Nucleic acid molecule RTN4BSR6 and application for preparation of anti-cancer drugs |
| 09/26/2007 | CN101041679A Structure of siRNA for target survivin gene and antineoplastic usage |
| 09/26/2007 | CN101041657A Imines derivative of 4,5-disubstituted-2-aminothiazole having anticancer action and preparation thereof |
| 09/26/2007 | CN101041651A Preparation method and usage for nitrogen-containing flavone derivatives |
| 09/26/2007 | CN101041646A Preparation method and usage for nitrogen-containing chalcone derivatives |
| 09/26/2007 | CN101041640A Antineoplastic active substance of diketopiperazine PJ147and PJ157 |
| 09/26/2007 | CN101041629A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 09/26/2007 | CN101041081A Rhenium anti-liver cancer single-anti-magnetic nanometer body and the method for preparing the same |
| 09/26/2007 | CN101041078A Biology agent for improving radiosensitization of tumor cells and the use thereof |
| 09/26/2007 | CN101041075A Biotinylated pulullan polysaccharide nanometer grains and the preparation method |
| 09/26/2007 | CN101041074A Anticancer compound including neoangiogenesis inhibitors and alkylate agent |
| 09/26/2007 | CN101041071A Interacted proteins of APC10 and the function for adjusting the cell period thereof |
| 09/26/2007 | CN101041043A Liver cancer treating traditional Chinese medicine |
| 09/26/2007 | CN101041016A Medicine for curing pituitary adenoma and its preparation method |
| 09/26/2007 | CN101041004A Novel antineoplastic compound medicine |
| 09/26/2007 | CN101040995A Valid target of garlic oil and the application in preparing many kinds of medicine |
| 09/26/2007 | CN101040959A Anticancer compound agent |
| 09/26/2007 | CN101040899A Antineoplastic Chinese traditional compound and the preparation and the method for producing the same |
| 09/26/2007 | CN101040885A Chinese traditional extraction and the function containing dammarane type four-ring triterpene sapogenin |
| 09/26/2007 | CN101040878A Chinese traditional medicine for treating esophagus cancer |
| 09/26/2007 | CN101040869A Nanometer elemental selenium coupled with liquid amino acid and the method for preparing and preserving the same |
| 09/26/2007 | CN101040865A Sustained-released injection including antimetabolite medicine and alkylate agent |
| 09/26/2007 | CN101040861A Anticancer compound including phosphatidylinostitol 3-kinase inhibitor and alkylate agent |
| 09/26/2007 | CN101040859A Anticancer compound including anticancer medicine and the synergistic agent |
| 09/26/2007 | CN101040848A Method for preparing amphiphilic nanoparticles |
| 09/26/2007 | CN101040844A Anticancer compound including alkylate agent and epothilones |
| 09/26/2007 | CN101040843A Solid tumor resisting release agent including nimustine and the intensifier |
| 09/26/2007 | CN101040841A Anticancer compound including phosphatidylinostitol 3-kinase inhibitor and alkaloid |
| 09/26/2007 | CN101040840A Anticancer compound including taxanes and phosphatidylinostitol 3-kinase inhibitor |
| 09/26/2007 | CN101040838A Anticancer compound including phosphatidylinositol 3-kinase inhibitor and alkylate |
| 09/26/2007 | CN101040836A Anti-cancer combination including phosphatidylinositol 3-kinase inhibitor and antimetabolite medicine |
| 09/26/2007 | CN100339474C Novel bacillus and its separation method and application |
| 09/26/2007 | CN100339415C Polymer guanidine derivatives as a cytostatic medicament |
| 09/26/2007 | CN100339394C 组织特异性表达 Tissue-specific expression |
| 09/26/2007 | CN100339393C PEG-conjugates of HGF-NK4 |
| 09/26/2007 | CN100339392C Liver cancer apoptosis inducing factor and its encoding gene and use |
| 09/26/2007 | CN100339382C Phospholipid derivatives and process for the production there |
| 09/26/2007 | CN100339379C 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 09/26/2007 | CN100339377C Camptothecine derivative and its preparation |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339375C Metabolites of ecteinascidin 743 |
| 09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
| 09/26/2007 | CN100339124C Guiyuan oral liquid and its preparing process |
| 09/26/2007 | CN100339098C Application of coptic toxin resolving decoction in preparation of medicine for predventing and treating tumour chemotherapy tolerance |
| 09/26/2007 | CN100339086C Medicine for preventing oral cavity cancer and its prepn |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/25/2007 | USRE39862 Unsaturated 14, 15-cyclopropanoandrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/25/2007 | US7273936 A 2-pyridyl derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses |
| 09/25/2007 | US7273920 Controlling protein levels in eucaryotic organisms |
| 09/25/2007 | US7273877 5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273873 Camptothecins with a modified lactone ring |
| 09/25/2007 | US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases |
| 09/25/2007 | US7273846 Selective melanin-concentrating hormone type-1 receptor agonists |